期刊文献+

原发性胆汁性肝硬化16例临床分析

Clinical analysis of 16 cases of primary biliary cirrhosis
下载PDF
导出
摘要 目的分析原发性胆汁性肝硬化(PBC)的临床特征,提高对于该病诊治的认识。方法分析16例PBC患者的一般资料、临床表现、血清学、免疫学指标等改变。结果本组患者中男女之比为1∶4.3,确诊时平均年龄(52.6±9.9)岁。最常见症状为乏力(68.8%)、皮肤瘙痒(43.8%)。所有患者碱性磷酸酶(ALP)及谷氨酰转肽酶(GGT)明显增高,分别为(452.44±365.45)U/L和(385.25±192.67)U/L,10例(62.5%)患者血清总胆红素(TB)增高,血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)水平呈轻至中度升高,分别为(94.13±48.38)U/L及(101.5±73.58)U/L。10例患者血清IgM增高,所有患者血清抗线粒体抗体(AMA)或AMA-M2亚型阳性。结论PBC好发于中老年女性,长期慢性乏力、皮肤瘙痒,血清ALP、GGT、TB及血清IgM水平升高及AMA/AMA-M2阳性有助于诊断本病。 Objective To study the clinical features of primary biliary cirrhosis (PBC) in order to better handle the treatment of the disease. Method The general conditions, clinical manifestations, and the results of serologic and immunologic tests were assessed in 16 patients. Results The ratio of male to female was 1:4.3, the mean age at definite diagnosis was (52.6 ±9.9) years. The most frequent symptoms were fatigue (68.8%) and pruritus (43.8%). Serum alkline phosphatase (ALP) and glutamyl transpeptidase (GGT) were markedly elevated [ (452.44 ± 365.45 )U/L and (385.25 ± 192.67)U/L, respectively]. Total bilirubin (TB) levels were elevated in 10 patients (62.5%). ALT and AST levels were mildly or moderately elevated [ (94.13 ±48.38) U/L and ( 101.5 ± 73.58) U/L , respectively]. IgM was also elevated in 10 patients. The positive rate of antimitochondrial antibody (AMA) or AMA -M2 subtype was 100%. Conclusions PBC mainly affects middle - aged women. Chronic fatigue, pruritus and the increase of serum ALP, GGT,TB, IgM and positive AMA or AMA -M2 subtype help to establish the diagnosis of primary biliary cirrhosis.
出处 《徐州医学院学报》 CAS 2008年第2期114-117,共4页 Acta Academiae Medicinae Xuzhou
关键词 原发性胆汁性肝硬化 诊断 抗线粒体抗体 primary biliary cirrhosis diagnosis antimitochondrial antibody
  • 相关文献

参考文献5

  • 1姚光弼.重视原发性胆汁性肝硬化的临床研究[J].中华肝脏病杂志,2002,10(5):325-326. 被引量:33
  • 2Heathcote EJ. Management of primary biliary cirrhosis. The Ameri - can Association for the Study of Liver Diseases practice guidelines [J]. Hepatology, 2000, 31(4):1005-1013.
  • 3Nakamura M, Kondo H, Mori T, et al. Anti - gp210 and anti - centromere antibodies are different risk factors for the progression of primary biliary cirrhosis [ J]. Hepatology ,2007,45 ( 1 ) : 118 - 127.
  • 4Leuschner M, Holtmeier J, Ackermann H, et al. The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxyeholie acid: a pilot study [J]. Eur J Gastreenterel Hepatol, 2002,14(12) : 1369 - 1376.
  • 5Wesierska - Gadek J, Penner E, Battezzati PM, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis [ J ]. Hepatology, 2006,43 (5) : 1135 - 1144.

二级参考文献1

  • 1Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guideline[].Hepatology.2000

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部